Endocrine 2 Flashcards

(53 cards)

1
Q

DM1

A
Autoimmune
Pancreatic beta cells destroyed
(Islets of Langerhans)
No insulin produced
Glucose ^^^
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DM2

A

Excess adipose tissue
Relative insulin deficiency
Glucose ^

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prediabetes

A

Not meeting DM2 criteria
Likely to develop DM2 in next few years
Require lifestyle interventions

Fasting glucose 6.1-6.9
HbA1c 42-47

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DM2 risk factors

A

Age ^
Family history
Non-white

Sedentary lifestyle
Obesity
Stress

GDM
PCOS

HTN
Dyslipidaemia
CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DM clinical features

A

Polydipsia
Polyuria
Weight loss
Fatigue

Visual disturbances
Abdo pain
N/V

Recurrent infections

  • Candidal
  • Skin
  • UTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Polydipsia/polyuria pathophysiology

A

Glycosuria
Water follows by osmosis
= Dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DM investigations

A

Random plasma glucose > 11

Fasting plasma glucose > 6.9

OGTT - 75g glucose - Wait 2 hours - Positive > 11

HbA1c > 48

Urine dip - Ketones +++

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DM1 management

A

Insulin

  • SC pump
  • 0.2-0.4 units/kg/day
  • BM self-monitoring
  • Pre-meal insulin correction dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DM2 management - Lifestyle

A

Lifestyle changes (HbA1c 48-53)

  • Weight loss 5-10%
  • Physical activity
  • Reduce alcohol intake - Risk of hypo
  • Smoking cessation

Diet - Reduce sugar consumption

  • High fibre
  • Low GI foods
  • Low-fat dairy produts
  • Reduced saturated fats and TFAs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DM sick day rules

A
Increase frequency of BM monitoring
Increase fluid intake - 3L / 24 hours
Maintain carbohydrate intake - Sugary drinks if necessary
Access to a mobile phone 
Continue medication - Except metformin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DM indications for admission

A
Inability to tolerate oral fluids
Persistent diarrhoea
Significant ketosis - Despite additional insulin
BM > 20 - Despite additional insulin
Lack of support at home
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DM2 management

A
  1. HbA1c 48-53 - Diet and exercise
  2. Metformin
  3. If HbA1c > 58 add…
    - Gliptin
    - Sulfonylurea
    - Pioglitazone
    - SGLT-2 inhibitor - Gliflozin
  4. If HbA1c > 58 - Add another
  5. If HbA1c > 58 and BMI > 35
    - Add GLP-1 mimetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DM drugs MoA

A

Metformin - CI if eGFR < 30

  • Increases insulin sensitivity
  • Decreases hepatic gluconeogenesis

Sulfonylurea - Gliclazide

  • Risk of hypoglycaemia
  • Stimulates pancreatic B cells to produce insulin

Pioglitazone

  • Promote adipogenesis and FFA uptake
  • Weight gain

Gliptins

  • Increases incretin
  • Inhibits glucagon secretion
  • Risk of pancreatitis

SGLT-2 inhibitors - Inhibits renal reabsorption of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DM complications

A

Microvascular

  • Neuropathy
  • Retinopathy
  • Neuropathy

Macrovascular

  • CVD
  • CHF
  • Stroke

Infection
DKA
Non-ketotic hyperosmolar state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DKA pathophysiology

A

Insulin deficiency + Glucagon ^
Triglycerides and AAs metabolised for energy
Increased serum glycerol and FFA
Glucagon converts FFA to ketones

Hyperglycaemia causes osmotic diuresis
Marked urinary loss of water and electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DKA clinical features

A

N/V
Abdo pain

Altered consciousness
Dehydration

Hyperventilation - Kussmaul breathing
Ketone breath - Pear drops

Sx of DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DKA investigations

A

VBG

  • Hyperkalaemia
  • Hypokalaemia = Severe DKA
  • Metabolic acidosis
  • Serum osmolality ^^^

pH < 7.3
Serum ketones > 3
BM > 11
Bicarb < 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DKA management

A

Fluid replacement

  • 500ml bolus over 10-15 minutes
  • 1L over 1 hour

Correct hypokalaemia - SandoK
Insulin - FR infusion

When glucose < 14 - Give 10% Dextrose

Safe rate of glucose reduction - 4-6 mmol/hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DKA complications

A

Arrhythmias - Hypo/hyperkalaemia
VTE

ARDS
Gastric stasis
AKI

Cerebral oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hyperosmolar hyperglycaemic state pathophysiology

A
Hyperglycaemia
Osmotic diuresis
- Electrolyte abnormalities 
- Severe dehydration 
- Raised serum osmolality
- Hyperviscosity

Typically elderly DM2 patients
Develops over many days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hyperosmolar hyperglycaemic state clinical features

A

Dehydration
Hypotension
Tachycardia

Fatigue
Lethargy
Weakness
Altered consciousness

N/V
Headaches
Papilloedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hyperosmolar hyperglycaemic state diagnosis criteria and management

A
  1. Hypovolaemia
  2. Hyperglycaemia > 30 ± Ketonaemia/acidosis
  3. Serum osmolality > 320

Management

  • Fluid replacement
  • Correct electrolyte abnormalities
  • Normalise blood glucose
23
Q

Thyroid storm precipitating events

A

MIST

Media - Contrast - Acute iodine load
Infection
Surgery
Trauma

24
Q

Thyroid storm clinical features

A

Fever > 38.5

Tachycardia
Hypertension
HF

Confusion and agitation
N/V

Abnormal LFTs
Jaundice

25
Thyroid storm management
Symptomatic - Paracetamol BBs - IV propranolol Carbimazole Dex - Blocks conversion of T3 to T4
26
Myxoedema coma Symptoms and management
Confusion Hypothermia Management - IV thyroxine - IV Fluid replacement - IV corticosteroids - Correct electrolyte imbalance - Rewarming?
27
Thyroid cancers
Presentation - Thyroid nodule in a woman aged 30-50 Papillary carcinoma - 70% - Young females - Excellent prognosis Follicular adenoma - 20% - Solitary thyroid nodule Medullary carcinoma - 5% - Secrete calcitonin - 20% familial genetics Anaplastic carcinoma - 1% - Pressure symptoms - Elderly females - Chemo ineffective Lymphoma - Associated with Hashimoto's
28
Thyroid nodule investigations
TSH - Normal USS + FNB Laryngoscopy - Paralysed vocal cord? CT staging Serum calcitonin - Medullary carcinoma
29
Thyroid cancer management
Total thyroidectomy Radioiodine ablation TSH suppression - Levothyroxine Screen for recurrence - Yearly thyroglobulin levels
30
Hypoadrenalism
Primary - TB - Metastases - Meningococcal septicaemia - HIV - Antiphospholipid syndrome Secondary - Pituitary disorders - Tumours - Irradiation - Infiltration
31
Pituitary adenoma risk factors
MEN-1 Familial isolated pituitary tumours - FIPA Carney complex - CNC
32
Pituitary adenoma clinical features
Headaches Bitemporal hemianopia Central adiposity Reduced muscle mass Hypogonadism - Gynaecomastia - Amenorrhoea - Infertility - Loss of libido - ED Hypothyroidism Fatigue Osteopenia Adrenal insufficiency - Anorexia - N/V - Weakness
33
Pituitary adenoma investigations
Prolactin ^ IGF-1 - Low with GH deficiency Sex hormones - LH, FSH, testosterone, oestrogen Morning cortisol ACTH ACTH stimulation test Insulin tolerance test U&E - Hyponatraemia FBC - Anaemia CT/MRI
34
Pituitary adenoma management
Pituitary apoplexy - Hydrocortisone - Levothyroxine - Trans-sphenoidal resection Adenoma - Observation - Hormone replacement - Radiotherapy - Dopamine agonist - Bromocriptine / Cabergoline - Somatostatin analogue - Octreotide
35
PTH physiology and vit D synthesis
PTH released in response to low Ca - Increased bone resorption by OCs - More Ca released - Increased Ca reabsorption in kidneys - Increased vit D synthesis in kidney - Increased calcium and phosphate absorption from gut 25-hydroxyvitamin D Converted to 1,25-dihydroxyvitamin D Absorbed in gut
36
HyperPTH aetiology
Primary - Solitary adenoma Secondary - Hyperplasia Risk factors - Female - Age > 50 - Family history - MEN - Li treatment
37
HyperPTH clinical features
= Hypercalcaemia ``` Bones - Osteoporosis, osteopenia, pain Stones - Renal Moans - Depression and anxiety Groans - Abdominal pain and myalgia Thrones - Constipation ``` Sleep disturbances Fatigue Cognitive changes Paraesthesia
38
HyperPTH investigations
Calcium profile - Calcium ^ (Low in 2) - Phosphate ^ (Low in 2) - PTH ^ - ALP ^ Tech-99 scan ECG - Short QT Skeletal survey - Pepper pot skull Knee XR - Chondrocalcinosis
39
HyperPTH management
Parathyroidectomy + Vit D supplementation - Ergocalciferol + Alendronic acid + Cinacalcet
40
HypoPTH aetiology
Thyroid/parathyroid surgery Malnutrition Malabsorption Diarrhoea Chronic alcoholism Hypomagnesaemia AD conditions - CASR and GATA3
41
HypoPTH clinical features
Secondary to hypocalcaemia Tetany - Muscle twitches, spasms, cramps Perioral paraesthesia Trosseau's sign - Carpal spasm on inflation of BP cuff Chvostek's sign - Tapping parotid causes facial muscles to twitch ``` Depression Cognitive changes Anxiety Dry hair and brittle nails Cataracts ```
42
HypoPTH investigations and management
Calcium profile - Ca - LOW - PTH - LOW - Phosphate ^ - Vit D - LOW Albumin - Low albumin will falsely lower serum calcium - Ionised calcium accurately reflects physiological calcium Magnesium - LOW ECG - Prolonged QT Management - Calcium carbonate - Calcitriol
43
Hypernatraemia aetiology
Dehydration Osmotic diuresis DI Infancy Old age Renal concentrating deficit Iatrogenic - IV saline - Lithium - Mannitol
44
Hypernatraemia clinical features
CNS manifestations - Lethargy/weakness - Irritability - IC haemorrhage - Seizures - Stupor - Coma Weight loss - Hypovolaemia Hypo/tachy Decreased JVP Dry mucous membranes
45
Hypernatraemia investigations and management
Serum sodium Urine osmolality - Low - DI - High - Volume depletion Serum osmolality - High Management - Treat cause - Fluid replacement - DI - Desmopressin / Thiazide diuretic
46
Carcinoid syndrome aetiology
Metastases in the liver Serotonin released into systemic circulation Risk factors - MEN-1
47
Carcinoid syndrome clinical features
Flushing Palpitations Diarrhoea Abdo cramps Signs of RHF Cardiac murmurs Hepatomegaly
48
Carcinoid syndrome investigations and management
Serum chromogranin A/B ^^^ Urinary 5-hydroxyindoleacetic acid ^^^ Creatinine ^^^ LFTs Management - Somatostatin analogue - Octreotide
49
Multiple endocrine neoplasia
``` MEN-1 - 3Ps - Parathyroid - Pituitary - Pancreas + Adrenal + Thyroid ``` MEN-2a - 2Ps - RET oncogene - Medullary thyroid cancer - Parathyroid - Phaeochromocytoma MEN-2b - 1P - RET oncogene - Phaeochromocytoma - Marfanoid body habitus - Neuromas
50
Phaeochromocytoma
Catecholamine secreting tumour Associated with - MEN-2 - Neurofibromatosis - Von-Hippel Lindau syndrome 10% rule - Familial in 10% - Bilateral in 10% - Malignant in 10% - Extra-adrenal in 10% - Organ of Zuckerlandl
51
Phaeochromocytoma clinical features
HTN - 90% 1. Headaches 2. Palpitations 3. Diaphoresis ``` Hypertensive retinopathy Pallor DM Orthostatic hypotension Cafe au lait spots ```
52
Phaeochromocytoma investigations
24-hour urine collection - Catecholamines - Metanephrines - Normetanephrines - Creatinine MRI - Adrenal medulla Genetic testing
53
Phaeochromocytoma management
AB - Phenoxybenzamine BB - Propranolol + Surgical excision